Tecmed (Pty) Limited and Others v Nissho Iwai Corporation and Another

Nissho Iwai Corporation instituted action in February 2003 against Tecmed (Pty) Ltd and four sureties for payment arising from a distributorship agreement and related suretyships. After litis contestatio, Nissho Iwai merged under Japanese law with Nichimen Corporation in an absorption merger effective 1 April 2004, resulting in Nichimen (renamed Sojitz Corporation) universally succeeding to all assets, liabilities, rights and obligations of Nissho Iwai, which was dissolved. A Rule 15 notice was served in 2006 purporting to substitute Sojitz as plaintiff. This triggered multiple interlocutory applications concerning the validity of the Rule 15 notice, attorneys’ authority, substitution of the plaintiff, intervention by Sojitz, and whether substitution would cause prescription of the claim. The High Court granted substitution and dismissed the defendants’ objections. The defendants appealed to the Supreme Court of Appeal.

The appeal was dismissed with costs, including the costs of two counsel, and the order substituting Sojitz Corporation as plaintiff was confirmed.

The case clarifies South African procedural law where a litigating party undergoes universal succession by operation of foreign law after litis contestatio. It confirms that such succession does not interrupt proceedings or trigger prescription under s 15(2) of the Prescription Act, and that the successor is treated as the same litigant. The judgment provides important guidance on substitution of parties, Rule 15, and the distinction between universal succession and cession.